ARTICLE | Clinical News
Endostatin recombinant human endostatin protein fragment of collagen XVIII regulatory update
August 20, 2001 7:00 AM UTC
The FDA granted Orphan Drug designation for ENMD's Endostatin antiangiogenesis protein candidate to treat neuroendocrine tumors. The product is in Phase I testing for the indication. ...